ID
Campylobacter jejuni
search
Campylobacter jejuni
, Campylobacteriosis, Campylobacter Colitis
See Also
Diarrhea
Infectious Diarrhea
Epidemiology
Among the most common causes of
Infectious Diarrhea
Responsible for 5-14% of worldwide
Diarrhea
In some years in the U.S., Campylobacter jejuni may cause 2 million cases of
Infectious Diarrhea
Very common in Southeast asia
Pathophysiology
Characteristics
Campylobacter jejuni is a facultative Anaerobic
Gram Negative Rod
in
Vibrionaceae
family
Like
Vibrio
species, Campylobacter jejuni is curved, and motile with a single polar flagellum
Virulence
Heat labile
Enterotoxin
(LT)
Campylobacter jejuni binds and invades intestinal epithelium
May spread systemically in
Immunocompromised
hosts
Similar to
Salmonella typhi
or
Yersinia enterocolitica
Sources
Natural Hosts: Wild birds and ducks (natural reservoir of zoonotic disease)
Also found in domestic animals including poultry
Waterborne Illness
Fecal oral route of contaminated water
Foodborne Illness
Gastroenteritis
(sporadic cases of
Traveler's Diarrhea
are common)
Outbreaks (e.g. unpasteurized milk, esp. in children)
Risk Factors
Use of prophylactic
Antibiotic
s (
Traveler's Diarrhea Prevention
)
Symptoms
Course
Onset in 3-5 days
Duration 2-10 days
Prodrome
Low grade fever (>50% of cases)
Headache
Myalgias
Abdominal Pain
or cramping
Watery, bloody
Diarrhea
(follows prodrome by <1 day)
Diarrhea
is self limited in immunocompetent hosts
Mild cases: Asymptomatic excretion
Severe cases:
Dysentery
(with bloody
Diarrhea
)
Labs
Stool Culture
Very difficult to culture
Requires selective growth medium (Campy Blood Agar)
Darkfield microscopy
Phase contrast microscopy
Management
Antibiotic
s
Antibiotic
indications (longer course for
Immunocompromised
patients)
Dysentery
(
Inflammatory Diarrhea
)
Sepsis
May be indicated in enteritis
First-line agents
Azithromycin
(
Zithromax
) 500 mg orally daily for 3 days
Treat for 14 days if associated with bacteremia (which is rare)
Alternative agents
Erythromycin
500 mg orally four times daily for 3 days
Ciprofloxacin
500 mg orally twice daily for 5 days
Fluoroquinolone
(high resistance rate >50-85%)
References
(2016) Sanford Guide to Antimicrobial Therapy, accessed 5/7/2016
Complications
Guillain-Barre Syndrome
Reactive Arthritis
References
Kaakoush (2015) Clin Microbiol Rev 28(3):687-720 +PMID: 26062576 [PubMed]
Type your search phrase here